13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-13, with 52 holding rows worth $261,839,408.
- Accession
- 0001214659-25-011950
- Filer
- CIK 1482416
- Filed
- 2025-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 52 entries on the cover page, a total value of $261,839,408 stated on the cover page (in dollars after the unit check, H1), rows summing to $261,839,408 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MAXIMUS INC | 577933104 | COM | 548,086 | $38,475,637 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 284,787 | $15,082,320 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 245,570 | $14,493,541 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 262,500 | $14,248,500 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 173,951 | $13,769,961 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 512,338 | $13,377,145 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 100,725 | $12,660,125 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 225,114 | $12,374,517 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 4,095,764 | $9,829,834 | dollars as filed | |
| IDEXX LABS INC COM | 45168D104 | Stock | 18,000 | $9,654,120 | dollars as filed | put |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 187,500 | $9,058,125 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 810,274 | $7,754,322 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 112,923 | $7,368,226 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 539,730 | $7,075,860 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 1,839,022 | $6,969,893 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 584,435 | $6,177,478 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 158,736 | $4,936,690 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 236,070 | $4,397,984 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 2,075,139 | $4,233,284 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 3,735,396 | $3,959,520 | dollars as filed | |
| AVANOS MED INC | 05350V106 | COM | 288,849 | $3,535,512 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 62,719 | $3,299,019 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 947,489 | $3,136,189 | dollars as filed | |
| INMUNE BIO INC | 45782T105 | COM | 1,299,300 | $3,001,383 | dollars as filed | put |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 1,307,964 | $2,799,043 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 241,000 | $2,749,810 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 124,230 | $2,611,315 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 335,937 | $2,422,106 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 478,343 | $2,410,849 | dollars as filed | |
| NEUROONE MED TECHNOLOGIES CORP COM | 64130M209 | Stock | 3,523,663 | $2,390,101 | dollars as filed | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 4,852,298 | $2,311,635 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 122,210 | $1,808,708 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,369,748 | $1,739,580 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 318,256 | $1,705,852 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 726,851 | $1,657,220 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 178,774 | $1,351,531 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 636,300 | $1,234,422 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 845,531 | $1,183,743 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,341,636 | $879,040 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 2,232,000 | $736,337 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 785,824 | $585,439 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 122,889 | $577,578 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 279,369 | $472,134 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 50,839 | $380,276 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 72,173 | $360,143 | dollars as filed | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 31,169 | $302,028 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 163,679 | $165,316 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 131,300 | $60,398 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 10,100 | $37,673 | dollars as filed | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $18,749 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 400,000 | $13,620 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 1,100 | $5,577 | dollars as filed | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-25-011950 | this filing | 2025-08-13 | acceptance time not in the bulk data set |